Disease Category Overview Template: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Under Construction}} | {{Under Construction}} | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Put your text here | Put your text here | ||
__TOC__ | |||
==Graphical Data Links== | ==Graphical Data Links== | ||
| Line 14: | Line 17: | ||
==WHO Classification Pages (Includes Links to Content)== | ==WHO Classification Pages (Includes Links to Content)== | ||
Put your text here | Put your text here (use "Link" icon at top of page) | ||
==Other Related Pages (Includes Links to Content)== | ==Other Related Pages (Includes Links to Content)== | ||
Put your text here | Put your text here (use "Link" icon at top of page) | ||
==Additional Information== | ==Additional Information== | ||
| Line 25: | Line 28: | ||
==References== | ==References== | ||
(use "Cite" icon at top of page) | |||
<references /> | |||
=== EXAMPLE Book === | === EXAMPLE Book === | ||
#Arber DA, et al., ( | #Arber DA, et al., (2017). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p129-171. | ||
== Notes == | == Notes == | ||
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | ||